Jpmorgan Chase & CO Pulmonx Corp Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
A detailed history of Jpmorgan Chase & CO transactions in Pulmonx Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 264,575 shares of LUNG stock, worth $1.68 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
264,575
Previous 52,263
406.24%
Holding current value
$1.68 Million
Previous $666,000
268.17%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding LUNG
# of Institutions
124Shares Held
30.8MCall Options Held
1.2KPut Options Held
1.2K-
Primecap Management CO Pasadena, CA5.74MShares$36.4 Million0.04% of portfolio
-
Black Rock Inc. New York, NY3.04MShares$19.3 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.72MShares$17.2 Million0.06% of portfolio
-
Morgan Stanley New York, NY2.65MShares$16.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.08MShares$13.2 Million0.0% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $236M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...